High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
- PMID: 22234969
- PMCID: V体育ios版 - PMC4610360
- DOI: V体育2025版 - 10.1002/hep.25572
"VSports在线直播" High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases
"V体育ios版" Abstract
Hypoxia is often found in solid tumors and is associated with tumor progression and poor clinical outcomes. The exact mechanisms related to hypoxia-induced invasion and metastasis remain unclear. We elucidated the mechanism by which the nuclear-damage-associated molecular pattern molecule, high-mobility group box 1 (HMGB1), released under hypoxic stress, can induce an inflammatory response to promote invasion and metastasis in hepatocellular carcinoma (HCC) cells VSports手机版. Caspase-1 activation was found to occur in hypoxic HCC cells in a process that was dependent on the extracellular release of HMGB1 and subsequent activation of both Toll-like receptor 4 (TLR4)- and receptor for advanced glycation endproducts (RAGE)-signaling pathways. Downstream from hypoxia-induced caspase-1 activation, cleavage and release of proinflammatory cytokines interleukin (IL)-1β and -18 occurred. We further demonstrate that overexpression of HMGB1 or treatment with recombinant HMGB1 enhanced the invasiveness of HCC cells, whereas stable knockdown of HMGB1 remarkably reduced HCC invasion. Moreover, in a murine model of HCC pulmonary metastasis, stable knockdown of HMGB1 suppressed HCC invasion and metastasis. .
Conclusion: These results suggest that in hypoxic HCC cells, HMGB1 activates TLR4- and RAGE-signaling pathways to induce caspase-1 activation with the subsequent production of multiple inflammatory mediators, which, in turn, promote cancer invasion and metastasis. V体育安卓版.
Copyright © 2012 American Association for the Study of Liver Diseases V体育ios版. .
VSports手机版 - Figures








References
-
- Rampone B, Schiavone B, Confuorto G. Current management of hepatocellular cancer. Curr Oncol Rep. 2010;12:186–192. - PubMed
-
- Llovet JM, Di Bisceglie AM, Bruix J, Kramer BS, Lencioni R, Zhu AX, Sherman M, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:698–711. - PubMed
-
- Talwalkar JA, Gores GJ. Diagnosis and staging of hepatocellular carcinoma. Gastroenterology. 2004;127:S126–132. - PubMed
-
- Lu SC, Mato JM. Role of methionine adenosyltransferase and S-adenosylmethionine in alcohol-associated liver cancer. Alcohol. 2005;35:227–234. - PubMed
-
- Di Bisceglie AM, Simpson LH, Lotze MT, Hoofnagle JH. Development of hepatocellular carcinoma among patients with chronic liver disease due to hepatitis C viral infection. J Clin Gastroenterol. 1994;19:222–226. - PubMed
Publication types
- "VSports注册入口" Actions
MeSH terms (V体育官网入口)
- V体育平台登录 - Actions
- VSports - Actions
- Actions (V体育2025版)
- Actions (V体育安卓版)
- "V体育平台登录" Actions
- "VSports" Actions
Substances (V体育平台登录)
- "VSports在线直播" Actions
- Actions (VSports在线直播)
- Actions (VSports注册入口)
Grants and funding
LinkOut - more resources
Full Text Sources
Other Literature Sources
Medical